Verified
My stiffness eased during the morning and I could move around the kitchen more easily. Sleep became lighter during the first week, so the timing of the evening dose had to change.
22 Oct 2026
Active ingredient: Amantadine
Amantadine
Quality products
24/7 Support
Fast delivery
Delivery
from 4 days
Amantadine is an oral medicine for people managing Parkinson’s motor symptoms or some drug-induced involuntary movements. It may reduce stiffness and dyskinesia by changing dopamine activity and blocking NMDA-type glutamate receptors in the brain.
Description
Amantadine is the active ingredient in an oral medicine used in Parkinson’s disease and some drug-induced involuntary movements. It belongs to the class of glutamate antagonist drugs and also affects dopamine transmission.
Composition
The product is supplied as capsules containing amantadine. The exact strength and release characteristics determine the dosing schedule, so the prescribed dose must be followed rather than adjusted based on symptom severity.
Dosage and usage
Amantadine treatment is commonly introduced cautiously. A prescriber may increase the dose in stages when symptom control remains inadequate and tolerability is acceptable. Kidney function has a major effect on amantadine clearance, which means people with reduced renal function may need a lower dose or a longer interval between doses [2].
Administration principles
- Take the capsule by mouth at the prescribed times.
- Swallow it with water.
- Do not open, crush, or chew a modified-release capsule.
- Take late doses only according to the prescribed schedule, since amantadine may disturb sleep.
- If a dose is missed, take it when remembered unless the next dose is close; do not double the amount.
- Do not stop long-term treatment suddenly without a planned reduction.
A missed dose is usually managed by returning to the regular schedule. Taking two doses together can increase dizziness, confusion, agitation, or other nervous-system reactions.
If amantadine causes vivid dreams or insomnia, the timing of the last daily dose may matter. A prescriber can adjust the schedule without changing the total daily amount.
How it works
Amantadine is a glutamate antagonist drug with additional effects on dopamine transmission. Its activity is more complex than simple dopamine replacement. The medicine can influence dopamine release, reduce dopamine reuptake, and block NMDA receptors, which are activated by the neurotransmitter glutamate [1].
NMDA receptor antagonism
NMDA receptors help regulate excitatory signalling between nerve cells. Excessive excitatory activity may contribute to abnormal motor output in Parkinson’s disease and to levodopa-related dyskinesia. By reducing NMDA receptor activity, amantadine may dampen some of these abnormal signals.
Dopamine-related effects
Amantadine can increase dopaminergic activity in the basal ganglia, the brain structures that coordinate movement. This effect differs from the action of dopamine agonists, which stimulate dopamine receptors directly, and from levodopa, which is converted into dopamine.
Adenosine A2A antagonists affect another pathway involved in Parkinson’s motor control. They are pharmacologically distinct from amantadine, even though both approaches may influence motor circuits without being identical to dopamine replacement.
Indications
Management of Parkinson’s disease symptoms
Parkinson’s disease involves reduced dopamine signalling in brain circuits responsible for movement. Symptoms may include stiffness, slowness, tremor, reduced arm swing, and difficulty initiating movement. Amantadine may improve some motor symptoms through a combination of dopaminergic and glutamatergic effects.
It is often used alongside levodopa or another Parkinson’s treatment rather than as the only long-term medicine. The choice depends on the dominant symptoms, age, kidney function, cognitive status, sleep pattern, and other medicines.
Reduction of levodopa-induced dyskinesia
Levodopa remains one of the strongest medicines for Parkinson’s movement symptoms, but involuntary movements can appear as treatment continues. Amantadine may reduce the severity or frequency of these movements by moderating excessive glutamate signalling.
The benefit is not always immediate, and dyskinesia can fluctuate during the day. A treatment plan may need adjustment if movements worsen during medication “on” periods or if stiffness returns when levodopa wears off.
Keep a brief record of stiffness, tremor, involuntary movements, sleep, and unusual behaviour during the day. Timing patterns can help a prescriber distinguish dyskinesia from wearing-off symptoms.
Comparison
Amantadine occupies a different position from standard dopamine replacement and anticholinergic therapy. It may be useful when dyskinesia is prominent, while other medicines may be selected for bradykinesia, tremor, or wearing-off episodes.
| Treatment approach | Main role and limitation |
|---|---|
| Amantadine | NMDA-related and dopaminergic effects; may reduce dyskinesia, but can cause insomnia, hallucinations, or confusion |
| Levodopa | Strong relief of bradykinesia and rigidity; long-term treatment may be associated with motor fluctuations and dyskinesia |
| Trihexyphenidyl | May help tremor in selected younger adults; anticholinergic effects limit use in older people and those with cognitive risk |
Sinemet contains levodopa with carbidopa and works by increasing dopamine formation in the brain. Amantadine does not replace levodopa, so it is usually considered an add-on or alternative only in selected clinical circumstances.
Contraindications
- Severe kidney impairment or rapidly changing renal function
- Previous serious reaction to amantadine
- Epilepsy or a history of seizures
- Untreated glaucoma or significant visual pressure problems
- Recurrent fainting or serious heart-rhythm disease
- Active psychosis, severe confusion, or poorly controlled bipolar symptoms
- Pregnancy or breastfeeding when the expected benefit has not been assessed
- A history of compulsive gambling, shopping, sexual behaviour, or binge eating
When this is not for you
NOT for you if you have severe kidney impairment, a previous serious reaction, uncontrolled psychosis, or no clinician available to monitor new confusion or hallucinations.
Amantadine can worsen confusion, hallucinations, anxiety, or insomnia. People with Parkinson’s disease who already experience visual hallucinations may need closer monitoring after treatment begins.
Medicines that can intensify anticholinergic effects may increase dry mouth, constipation, blurred vision, urinary difficulty, or confusion. Other dopaminergic medicines may increase dyskinesia, hallucinations, restlessness, or sleep disruption. Alcohol can add to dizziness and impaired judgement.
Side effects
Amantadine can affect the nervous system, cardiovascular system, gastrointestinal tract, and sleep pattern. Side effects are more likely when the dose is too high for kidney function or when several medicines with central nervous-system effects are combined.
Commonly reported reactions include:
- Dizziness or light-headedness
- Nausea or reduced appetite
- Dry mouth
- Constipation
- Ankle swelling
- Blurred vision
- Insomnia or vivid dreams
- Feeling nervous or restless
Hallucinations, confusion, severe agitation, fainting, marked weakness, or new uncontrolled behaviour require prompt clinical assessment. Older adults and people with cognitive impairment can be more sensitive to confusion and hallucinations.
A mottled, purplish skin pattern called livedo reticularis can occur, often on the legs. It is not always dangerous, but it should be reported because it may accompany swelling or circulation-related problems.
Common mistakes
Several practical errors can reduce benefit or increase adverse effects:
- Increasing the dose without waiting for the planned review.
- Taking a late dose close to bedtime and then attributing insomnia to Parkinson’s itself.
- Continuing the same dose after kidney function has declined.
- Stopping suddenly after prolonged use.
- Crushing a capsule that is designed to release medicine gradually.
- Ignoring new gambling, spending, sexual, or eating behaviours.
- Treating hallucinations as an unavoidable part of Parkinson’s disease.
- Adding over-the-counter medicines with anticholinergic effects without checking the combination.
- Driving while dizzy, confused, or unusually sleepy.
A sudden change in alertness, balance, or behaviour may reflect amantadine accumulation rather than disease progression. Record when the change began and whether it followed a dose adjustment.
What doctors say
In clinical practice, amantadine is often considered when Parkinson’s symptoms remain troublesome despite a levodopa-based regimen, or when dyskinesia limits the useful dose of levodopa. The practical question is not simply whether the medicine can improve movement; it is whether the improvement outweighs sleep, mental-status, swelling, or balance problems.
A physician usually reviews kidney function, falls, hallucinations, daytime sleepiness, and the exact timing of levodopa doses. The same capsule can be helpful for one patient and poorly tolerated by another because clearance and brain sensitivity differ substantially.
Patients sometimes expect amantadine to remove every tremor or restore normal movement. Its benefit is usually selective. It may help stiffness or dyskinesia while having little effect on balance, speech, freezing, or non-motor Parkinson’s symptoms.
Frequently asked questions
How long does Amantadine take to work?
Some people notice improved movement within days, while the effect on dyskinesia may require a longer assessment period. FDA prescribing information (2018) and Parkinson’s Foundation clinical education (2024) describe response as variable, with tolerability often guiding dose adjustments. The expected timeframe also depends on the formulation and the other Parkinson’s medicines being used.
Can Amantadine be taken with levodopa?
Amantadine can be combined with levodopa in selected Parkinson’s treatment plans. The EMA (2017) describes combination treatment as a clinical decision because dopaminergic effects may become additive. Watch for increased dyskinesia, hallucinations, nausea, dizziness, or sleep disturbance after either medicine is changed.
Does Amantadine cause insomnia?
Insomnia, vivid dreams, and increased alertness are recognised reactions. MedlinePlus (2024) advises reporting troublesome nervous-system effects and following the prescribed schedule rather than moving doses independently. A clinician may place the final dose earlier in the day or reassess the total amount.
Is Amantadine addictive?
Amantadine is not classified as a controlled substance in the same way as opioid analgesics or traditional stimulant drugs. The FDA safety information (2018) still describes confusion, hallucinations, agitation, and unusual behaviour as possible reactions. Sudden discontinuation after long-term use can also cause problems, so withdrawal should follow a planned reduction.
Can Amantadine be stopped suddenly?
Stopping suddenly may lead to a marked return of Parkinson’s symptoms and, in some cases, confusion, agitation, or severe neurological deterioration. The Parkinson’s Foundation (2024) advises gradual changes to Parkinson’s medicines under clinical supervision. The reduction schedule depends on treatment duration, dose, kidney function, and concurrent medicines.
Can Amantadine be used during pregnancy or breastfeeding?
Pregnancy and breastfeeding require an individual risk assessment because human safety data are limited. The WHO’s 2023 medication-safety principles support weighing maternal benefit against fetal or infant exposure for medicines affecting the central nervous system. The treatment plan should be settled before starting, stopping, or restarting the medicine.
Is Amantadine suitable for pets?
Veterinary use may be appropriate for selected cases of chronic neuropathic pain, but human dosing cannot be transferred directly to an animal. The American Veterinary Medical Association (2024) supports species-specific prescribing and monitoring for adverse reactions. A pet should receive amantadine only within a veterinary treatment plan.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Veterinary applications and animal use
Veterinary clinicians may use amantadine as an adjunct for chronic neuropathic pain in dogs and other animals. Its use in pets depends on the animal’s species, weight, kidney function, pain diagnosis, and other medicines.
Human capsules should not be given to a pet without a veterinary dose calculation. Animal dosing can differ substantially, and some formulations or added ingredients may be unsuitable for a particular species.
Amantadine: Reviews and Experiences
3
Based on 4 reviews
Verified
The involuntary movements became less forceful after several weeks. I still had freezing when turning, so the medicine helped one part of the problem rather than everything.
28 Oct 2026
Verified
I became confused and saw things that were not there after a dose change. The symptoms improved after the treatment was reviewed and reduced.
30 Sept 2026
Verified
Dizziness was annoying at first, especially when standing up. Drinking enough fluid and rising slowly helped, but I still needed a clinical review.
12 Oct 2026
Sources
- Cochrane Database of Systematic Reviews (2003). Amantadine for dyskinesia in Parkinson’s disease.
- European Medicines Agency (2017). Guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease.
